Low Molecular Weight Heparins Can Lead To Hyperkalaemia
The Internet Journal of Geriatrics and Gerontology · 2005
DOI: 10.5580/10be ↗At a glance
Journal article in The Internet Journal of Geriatrics and Gerontology, 2005.
Abstract (original language)
Low molecular weight heparins (LMWH) have an important role in the management of many clinical conditions, either prophylactically or therapeutically.1,2,3 They are known to cause side-effects such as haemorrhage, thrombocytopenia, hypersensitivity reactions, skin necrosis and osteoporosis.1 Hyperkalaemia is a recognised side-effect of heparin and LMWH use, but this may be easily overlooked in a clinician's day-to-day practise.1,2,3,4,5 A case of Clexane (enoxaparin) induced hyperkalaemia in an elderly patient on a surgical ward is described.
Cite
APA
(2005). Low Molecular Weight Heparins Can Lead To Hyperkalaemia. The Internet Journal of Geriatrics and Gerontology. https://doi.org/10.5580/10be
Vancouver
Low Molecular Weight Heparins Can Lead To Hyperkalaemia. The Internet Journal of Geriatrics and Gerontology. 2005. doi:10.5580/10be
BibTeX
@article{euvimed2005,
title = {Low Molecular Weight Heparins Can Lead To Hyperkalaemia},
journal = {The Internet Journal of Geriatrics and Gerontology},
year = {2005},
doi = {10.5580/10be}
}
EUVIMED